Immunomodulation in cancer therapeutics

M. Jane Ehrke(Roswell Park Comprehensive Cancer Center)

International Immunopharmacology

February 28, 2003

10.1016/s1567-5769(03)00021-3

Cited by 97

Abstract

Related Papers

Adoptive T Cell Therapy of Tumors: Mechanisms Operative in the Recognition and Elimination of Tumor Cells

Philip D. Greenberg|Advances in immunology|1991|607

The reticuloendothelial system: A comprehensive treatise

|General Pharmacology The Vascular System|1984|208

Enhancement of Dinitrochlorobenzene (DNCB) Contact Sensitization by Cyclophosphamide in the Guinea Pig**From the Department of Dermatology, University of Pennsylvania, School of Medicine, Philadelphia, Pennsylvania 19104.

Henry Maguire, Von L. Ettore|Journal of Investigative Dermatology|1967|133

Increased primary cell-mediated immunity in culture subsequent to adriamycin or daunorubicin treatment of spleen donor mice.

Frank R. Orsini, Zlatko P. Pavelić, Enrico Mihich|The Mouseion at the JAXlibrary (Jackson Laboratory)|1977|85

Adriamycin and daunorubicin: a comparison of antitumor activities and tissue uptake in mice following immunosuppression.

Herbert S. Schwartz, Gerald B. Grindey|PubMed|1973|84